ELIAS Animal Health Email Format
Biotechnology ResearchKansas, United States2-10 Employees
ELIAS Animal Health is a biotechnology research company focused on developing immunotherapies for canine cancers. Its pipeline includes an adoptive cell therapy and an oncolytic virotherapy, with the lead product described as combining an autologous vaccine with cell therapy to target a dog’s unique cancer cells. The company aims to improve clinical outcomes and quality of life for canine patients, potentially transforming cancer treatment in veterinary medicine. Based in Overland Park, Kansas, and operating with a small team, ELIAS Animal Health is positioned in the veterinary oncology segment of the broader biotechnology industry. Recent activity includes participation in the 2025 ACVIM Forum to present results from a study combining ECI with chemotherapy, and organizational updates such as adding a scientific advisor to its board.